CRISPR Therapeutics AG SEC filings

Filings

1. 4CRISPR Therapeutics AGCRSP2d

   CRISPR Therapeutics AG reports insider trading

   • George Simeon sold 14,514 shares at $49.63
   • Acquired 30,000 shares at $14
   • Indirect ownership of 69,687 shares

   Simeon George, reporting

2. 4CRISPR Therapeutics AGCRSP3d

   2 insider filings

   James R. Kasinger, insider filing for CRSP

   Show all 2

   • 4Insider filing for CRSP3d
   • 4Insider filing for CRSP3d

   James R. Kasinger, reporting

3. 144CRISPR Therapeutics AGCRSP4d

   CRISPR Therapeutics AG files Form 144

   • Filer: Simeon George
   • Securities: 14,514 shares
   • Date of sale: 10/14/2026

   Simeon George, reporting

4. 4CRISPR Therapeutics AGCRSPOct 8

   CRISPR Therapeutics AG reports insider trading

   • James R. Kasinger sold 1,990 shares on 10/06/2026
   • Sold at an average price of $60.04
   • Purchased 1,990 shares on 10/06/2026

   James R. Kasinger, reporting

5. 144CRISPR Therapeutics AGCRSPOct 8

   CRISPR Therapeutics AG files Form 144

   • Filer CIK: 0001708172
   • Seller: James Kasinger
   • Shares to be sold: 1990

   James R. Kasinger, reporting

6. 4CRISPR Therapeutics AGCRSPSep 24

   James R. Kasinger, insider filing for CRSP

   James R. Kasinger, reporting

7. 144CRISPR Therapeutics AGCRSPSep 22

   James R. Kasinger, planned sale of CRSP shares

   James R. Kasinger, reporting

8. 4CRISPR Therapeutics AGCRSPSep 21

   2 insider filings

   Ali Behbahani, insider filing for CRSP

   Show all 2

   • 4Insider filing for CRSPSep 21
   • 4Insider filing for CRSPSep 21

   Ali Behbahani, reporting

9. 144CRISPR Therapeutics AGCRSPSep 17

   Ali Behbahani, planned sale of CRSP shares

   Ali Behbahani, reporting

10. SCHEDULE 13G/ACRISPR Therapeutics AGCRSPAug 14

    Ownership stake disclosure by ORBIS INVESTMENT MANAGEMENT LTD (amended)

    ORBIS INVESTMENT MANAGEMENT LTD, filed by

11. 4CRISPR Therapeutics AGCRSPAug 11

    Raju Prasad, insider filing for CRSP

    Raju Prasad, reporting

12. 10-QCRISPR Therapeutics AGCRSPAug 3

    Quarterly report

13. 8-KCRISPR Therapeutics AGCRSPAug 3

    Current report

14. SCHEDULE 13G/ACRISPR Therapeutics AGCRSPJul 27

    Ownership stake disclosure by BlackRock, Inc. (amended)

    BlackRock, Inc., filed by

15. 4CRISPR Therapeutics AGCRSPJun 9

    10 insider filings

    Simeon George, insider filing for CRSP

    Show all 10

    • 4Insider filing for CRSPJun 9
    • 4Insider filing for CRSPJun 9
    • 4Insider filing for CRSPJun 9
    • 4Insider filing for CRSPJun 9
    • 4Insider filing for CRSPJun 9
    • 4Insider filing for CRSPJun 9
    • 4Insider filing for CRSPJun 9
    • 4Insider filing for CRSPJun 9
    • 4Insider filing for CRSPJun 9
    • 4Insider filing for CRSPJun 9

    Simeon George, reporting

16. S-8CRISPR Therapeutics AGCRSPJun 5

    Employee stock plan registration

17. 8-KCRISPR Therapeutics AGCRSPJun 4

    Current report

18. 4CRISPR Therapeutics AGCRSPJun 2

    3 insider filings

    James R. Kasinger, insider filing for CRSP

    Show all 3

    • 4Insider filing for CRSPJun 2
    • 4Insider filing for CRSPJun 2
    • 4Insider filing for CRSPJun 2

    James R. Kasinger, reporting

19. 4CRISPR Therapeutics AGCRSPJun 1

    Naimish Patel, insider filing for CRSP

    Naimish Patel, reporting

20. SCHEDULE 13G/ACRISPR Therapeutics AGCRSPMay 15

    Ownership stake disclosure by ORBIS INVESTMENT MANAGEMENT LTD (amended)

    ORBIS INVESTMENT MANAGEMENT LTD, filed by

21. SCHEDULE 13GCRISPR Therapeutics AGCRSPMay 14

    Ownership stake disclosure by Capital World Investors

    Capital World Investors, filed by

22. 10-QCRISPR Therapeutics AGCRSPMay 4

    Quarterly report

23. 8-KCRISPR Therapeutics AGCRSPMay 4

    Current report

24. SCHEDULE 13G/ACRISPR Therapeutics AGCRSPApr 30

    Ownership stake disclosure by ARK Investment Management LLC (amended)

    ARK Investment Management LLC, filed by

25. ARSCRISPR Therapeutics AGCRSPApr 21

    Annual report to shareholders

26. DEFA14ACRISPR Therapeutics AGCRSPApr 21

    Additional proxy materials

27. DEF 14ACRISPR Therapeutics AGCRSPApr 21

    Proxy statement

28. PRE 14ACRISPR Therapeutics AGCRSPApr 2

    Preliminary proxy statement

29. 4CRISPR Therapeutics AGCRSPMar 24

    4 insider filings

    James R. Kasinger, insider filing for CRSP

    Show all 4

    • 4Insider filing for CRSPMar 24
    • 4Insider filing for CRSPMar 24
    • 4Insider filing for CRSPMar 24
    • 4Insider filing for CRSPMar 24

    James R. Kasinger, reporting

30. 4CRISPR Therapeutics AGCRSPMar 17

    4 insider filings

    Naimish Patel, insider filing for CRSP

    Show all 4

    • 4Insider filing for CRSPMar 17
    • 4Insider filing for CRSPMar 17
    • 4Insider filing for CRSPMar 17
    • 4Insider filing for CRSPMar 17

    Naimish Patel, reporting

31. 8-KCRISPR Therapeutics AGCRSPMar 16

    Current report

Older filings on EDGAR